Quality of life in people living with HIV was lower in those who had weight gain from adherence to antiretroviral therapy.

Shares of GSK fell to below $30 around the time of the demerger, but have since recovered to about $36. The 20% gain over 34 ...

Presumptive measles immunity rates were low among patients with HIV at a large US clinic, indicating targeted solutions to increase vaccine uptake are need for this at-risk population.

Gilead (GILD) wins the backing of an EU panel for lenacapavir, its twice-yearly injectable for prevention of HIV in ...

DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...

If there’s one place that is rife with sensitive personal data, it’s hospitals. It’s why the United States federal government ...

Adults who switched from daily ART to long-acting cabotegravir-rilpivirine showed high levels of virologic suppression, high adherence, and greater treatment satisfaction after 2 years on the regimen, ...

A monthly pill would add to the growing number of choices for HIV preexposure prophylaxis, which is now seen as the best hope ...

SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the develo ...

Merck MRK recently launched two late-stage clinical studies to evaluate MK-8527, its investigational once-monthly oral pill ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced an update to their volunt ...

Local News Federal Judge blocks Idaho law requiring immigration checks for HIV treatment Without treatment, HIV patients face increased risks of death, cancer, heart attacks and strokes.